Antitubulin drugs are used very successfully in chemotherapy but their chemical structures are complex. Based on a previously performed crystallographic fragment screen, we here rationally designed the small molecule tubulin inhibitor Todalam. The compound displays a unique molecular mechanism of action by targeting a novel binding site in tubulin.
抗微管蛋白药物在化疗中的应用非常成功,但它们的
化学结构很复杂。基于之前进行的晶体片段筛选,我们合理设计了小分子微管蛋白
抑制剂Todalam。该化合物通过靶向微管蛋白中的新结合位点,展现出独特的分子作用机制。